Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy.
Blood Adv
; 5(23): 5179-5189, 2021 12 14.
Article
in En
| MEDLINE
| ID: mdl-34516611
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Mantle-Cell
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Language:
En
Journal:
Blood Adv
Year:
2021
Document type:
Article
Country of publication:
United States